---
title: "amfetamine - Attention deficit hyperactivity disorder"
sidebar: mydoc_sidebar
permalink: amfetamineattentiondeficithyperactivitydisorder2.html
toc: false 
---

{% include image.html url="images/amfetamineattentiondeficithyperactivitydisorder2.png" file="amfetamineattentiondeficithyperactivitydisorder2.png" alt="amfetamineattentiondeficithyperactivitydisorder2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000661 | amfetamine | Drug |
| InterPro:IPR001613 | monoamine oxidase | Protein |
| GO:0005739 | mitochondria | CellularComponent |
| MESH:D018377 | neurotransmitters | ChemicalSubstance |
| MESH:D001289 | Attention deficit hyperactivity disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Amfetamine | DECREASES ACTIVITY OF | Monoamine Oxidase |
| Monoamine Oxidase | LOCATED IN | Mitochondria |
| Mitochondria | INCREASES ABUNDANCE OF | Neurotransmitters |
| Neurotransmitters | REGULATES | Attention Deficit Hyperactivity Disorder |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00182#mechanism-of-action](https://go.drugbank.com/drugs/DB00182#mechanism-of-action){:target="_blank"}